Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This thing is so close to a major breakout!
MDBX. At new high for day. So close to a breakout with the low float imo.
MDBX....Just turned the corner and went green. Low float so can run very fast.
MDBX...Turned green quickly. Could run very fast with the low float. Easy $5 stock imo. Currently at $2.10
Moves very fast!
MDBX. Ready to bounce big imo. Moves very fast with the low float. $32 a year ago, now $2. Easy bounce to $5 imo.
MDBX......Low float and moves fast! A year ago was $32 now $2. Easy $5 stock imo soon.
It hit bottom. It bounced off the year low. Bouncing around a few cents up and down doesn't say anything about the overall picture. Plus we are one hour into the market being open. Long day ahead. We shall see what happens. Only matters where it closes.
Lol, not looking at the price a half hour in or one day. I don't stare at the price all day long like others here.
In my opinion the bottom was hit and this stock has reversed. Green days and momentum upwards. All of the weak hands are gone........people done over reacting to the lawsuit. One more positive pr by the company and we have lift off.
This thing going to $2.67 per share then $5.67 per share!
Oh then I agree....lol....sorry
To me, it's a win win. Two things will happen: 1. They settle out of court, the stock price shoots up. 2. They win the lawsuit, the stock shoots WAY up. People forget, the lawsuit is already priced in right now. Excellent buying opportunity imo. That's why I am in. Only green from this point forward.
I like EAPH and think the stock will be going up but what funds are buying in? Lol that is funny. No funds buying penny stocks. Again though, huge supporter of EAPH.
Reverse stock split = death in penny land. Great to day trade though after the sell off happens. Bad mistake by the company imo.
Yes settled out of court for way less than anyone even realizes imo. Then the stock will shoot way up imo again. $5 stock......watch it happen!
Slow and steady upwards. That's the best way. Next week huge pop!
MDBX. Consolidating nicely after nice run up all day. I believe ready for round 2 in the afternoon. Chart looking great!
MDBX. It's official. Broke resistance. up 13% and running.
MDBX. Breaking resistance imo.
MDBX. Breaking thru resistance. Could really take off today imo.
MDBX. Steadily moving up all morning. Now up 7%. Market likes the news that came out yesterday after the close.
I know a lot of shareholders bought in at 10....20....30.....40+ so naturally they are upset. I have had my share of stocks that have destroyed me as well. Seriously though, you can't tell me this isn't a $5 stock. That's exactly where it is headed in my opinion. Whether you believe in the company or not who cares. Great upside and likely going to $5.
Have upward momentum now. Chart looking great. Just had to shake out the weak hands yesterday. Could tell by the close yesterday things were reversing then the news last night was the icing on the cake. MDBX$$
MDBX. Chart looking great. Up 5%. Great news out after market close yesterday. Imo, $5 stock. Currently at $2.17
MDBX Chart looking great. Up 5%. Great news out after market closed yesterday. IMO, $5 stock. Currently at $2.17
MDBX $5 stock in my opinion. News from after the market yesterday. Currently at $2.17
Press Release: Medbox Founder Comments on Signing $15M Equity Deal
16 hours 32 minutes ago - DJNF
Medbox Founder Comments on Signing $15M Equity Deal
Founder Further Comments on Signing a Deal Transferring the Majority of His Shares to an Industry Player and Directing $5M of the Proceeds to Medbox Through Equity Purchase
LOS ANGELES, March 5, 2015 (GLOBE NEWSWIRE) -- P. Vincent Mehdizadeh, founder and current majority shareholder of Medbox, Inc. (OTCQB:MDBX) commented on executing a deal with Lizada Capital LLC, an investor in the field of legal cannabis products, that would result in the transfer of the majority of Mr. Mehdizadeh's shares of MDBX to that firm.
Under the agreement, which has six separate closings over 18 months, Lizada would purchase 22,160,000 shares, representing 2,000,000 preferred shares and 12,160,000 common shares of Medbox for upwards of $15 million. A total of $5 million of the funds have been designated for purchase of 2.5 million restricted shares of Medbox common stock, directly from Medbox, in the name of Mr. Mehdizadeh's holding company, PVM International, Inc.
"Prior to announcing the deal yesterday, the Medbox board of directors had approved the Lizada Capital LLC managing member to join the board of directors as my board appointment and also approved of that party making a substantial direct investment into the company for the purchase of restricted common stock," stated Vincent Mehdizadeh, founder and current majority shareholder of Medbox. "I also discussed the possibility of having Lizada step into my shoes as the majority shareholder of the company and shared the potential deal points with the Medbox board of directors and their attorneys weeks before a final agreement was reached with Lizada. While Medbox is not a direct party to this transaction, they have been in the loop and have been supportive in vetting Lizada's investment and its managing member's appointment to the Medbox board of directors. The next steps for the investment into Medbox will be signing subscription agreements with the company that will tie into each of the first 5 closings identified within the Lizada transaction. From what my attorneys and I can gather, the signing of subscription agreements with Medbox is simply a formality. I am happy to be bringing value to Medbox and its shareholders in this manner."
That's why it makes me nervous we are going to see a big drop unless something happens. I hope it does drop big personally so I can buy in real cheap. .015 range or lower I hope
MDBX News last night great for the company
Medbox Founder Comments on Signing $15M Equity Deal
Founder Further Comments on Signing a Deal Transferring the Majority of His Shares to an Industry Player and Directing $5M of the Proceeds to Medbox Through Equity Purchase
P. Vincent Mehdizadeh
15 hours ago
GlobeNewswire
LOS ANGELES, March 5, 2015 (GLOBE NEWSWIRE) -- P. Vincent Mehdizadeh, founder and current majority shareholder of Medbox, Inc. (MDBX) commented on executing a deal with Lizada Capital LLC, an investor in the field of legal cannabis products, that would result in the transfer of the majority of Mr. Mehdizadeh's shares of MDBX to that firm.
Under the agreement, which has six separate closings over 18 months, Lizada would purchase 22,160,000 shares, representing 2,000,000 preferred shares and 12,160,000 common shares of Medbox for upwards of $15 million. A total of $5 million of the funds have been designated for purchase of 2.5 million restricted shares of Medbox common stock, directly from Medbox, in the name of Mr. Mehdizadeh's holding company, PVM International, Inc.
"Prior to announcing the deal yesterday, the Medbox board of directors had approved the Lizada Capital LLC managing member to join the board of directors as my board appointment and also approved of that party making a substantial direct investment into the company for the purchase of restricted common stock," stated Vincent Mehdizadeh, founder and current majority shareholder of Medbox. "I also discussed the possibility of having Lizada step into my shoes as the majority shareholder of the company and shared the potential deal points with the Medbox board of directors and their attorneys weeks before a final agreement was reached with Lizada. While Medbox is not a direct party to this transaction, they have been in the loop and have been supportive in vetting Lizada's investment and its managing member's appointment to the Medbox board of directors. The next steps for the investment into Medbox will be signing subscription agreements with the company that will tie into each of the first 5 closings identified within the Lizada transaction. From what my attorneys and I can gather, the signing of subscription agreements with Medbox is simply a formality. I am happy to be bringing value to Medbox and its shareholders in this manner."
To view a copy of the executed agreement between the parties, please click on the link below:
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=10537768
About P. Vincent Mehdizadeh, Founder and Majority Shareholder at Medbox, Inc.
P. Vincent Mehdizadeh founded Medbox's main subsidiary, Medicine Dispensing Systems, in February 2008. He commenced operations for that company in 2010, and in December of 2011 sold that company to what became Medbox, Inc. Mr. Mehdizadeh served as senior consultant from December 2012 until May 10, 2013 for Medbox, Inc. and then transitioned to Chief Operations Officer and Board Chairman for Medbox, Inc. through May of 2014. Mr. Mehdizadeh was responsible for creating the two main patents behind the company's technology, helping to assemble the talented board/management team at Medbox, and also developing the concept behind the business models driving revenue for the company. Mr. Mehdizadeh was responsible for funding and the creation of the Marijuana Policy Project "Consume Responsibly" campaign, as well as the Americans For Safe Access "Medicate Responsibly" campaign. Mehdizadeh has donated over $2 million dollars to Americans for Safe Access (ASA), Marijuana Policy Project (MPP), Drug Policy Alliance (DPA), Law Enforcement Against Prohibition (LEAP), and St. Jude Children's Research Hospital.
About Lizada Capital LLC:
Lizada is a privately held entity formed in 2004 for the principal purpose of investing in emerging market opportunities. In 2013, following a two-year period of industry evaluation, the company started primarily focusing on the cannabis industry, Since then, Lizada has invested in public companies including GW Pharmaceuticals, AmeriCann and CannLabs and private companies, CDX, MJIC, Panther Capital, New Frontier, Noble Blends, Medicine Man Technologies, Las Vegas CannaPlex and Quigley's.
MDBX Great news for the company
Medbox Founder Comments on Signing $15M Equity Deal
Founder Further Comments on Signing a Deal Transferring the Majority of His Shares to an Industry Player and Directing $5M of the Proceeds to Medbox Through Equity Purchase
P. Vincent Mehdizadeh
15 hours ago
GlobeNewswire
LOS ANGELES, March 5, 2015 (GLOBE NEWSWIRE) -- P. Vincent Mehdizadeh, founder and current majority shareholder of Medbox, Inc. (MDBX) commented on executing a deal with Lizada Capital LLC, an investor in the field of legal cannabis products, that would result in the transfer of the majority of Mr. Mehdizadeh's shares of MDBX to that firm.
Under the agreement, which has six separate closings over 18 months, Lizada would purchase 22,160,000 shares, representing 2,000,000 preferred shares and 12,160,000 common shares of Medbox for upwards of $15 million. A total of $5 million of the funds have been designated for purchase of 2.5 million restricted shares of Medbox common stock, directly from Medbox, in the name of Mr. Mehdizadeh's holding company, PVM International, Inc.
"Prior to announcing the deal yesterday, the Medbox board of directors had approved the Lizada Capital LLC managing member to join the board of directors as my board appointment and also approved of that party making a substantial direct investment into the company for the purchase of restricted common stock," stated Vincent Mehdizadeh, founder and current majority shareholder of Medbox. "I also discussed the possibility of having Lizada step into my shoes as the majority shareholder of the company and shared the potential deal points with the Medbox board of directors and their attorneys weeks before a final agreement was reached with Lizada. While Medbox is not a direct party to this transaction, they have been in the loop and have been supportive in vetting Lizada's investment and its managing member's appointment to the Medbox board of directors. The next steps for the investment into Medbox will be signing subscription agreements with the company that will tie into each of the first 5 closings identified within the Lizada transaction. From what my attorneys and I can gather, the signing of subscription agreements with Medbox is simply a formality. I am happy to be bringing value to Medbox and its shareholders in this manner."
To view a copy of the executed agreement between the parties, please click on the link below:
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=10537768
About P. Vincent Mehdizadeh, Founder and Majority Shareholder at Medbox, Inc.
P. Vincent Mehdizadeh founded Medbox's main subsidiary, Medicine Dispensing Systems, in February 2008. He commenced operations for that company in 2010, and in December of 2011 sold that company to what became Medbox, Inc. Mr. Mehdizadeh served as senior consultant from December 2012 until May 10, 2013 for Medbox, Inc. and then transitioned to Chief Operations Officer and Board Chairman for Medbox, Inc. through May of 2014. Mr. Mehdizadeh was responsible for creating the two main patents behind the company's technology, helping to assemble the talented board/management team at Medbox, and also developing the concept behind the business models driving revenue for the company. Mr. Mehdizadeh was responsible for funding and the creation of the Marijuana Policy Project "Consume Responsibly" campaign, as well as the Americans For Safe Access "Medicate Responsibly" campaign. Mehdizadeh has donated over $2 million dollars to Americans for Safe Access (ASA), Marijuana Policy Project (MPP), Drug Policy Alliance (DPA), Law Enforcement Against Prohibition (LEAP), and St. Jude Children's Research Hospital.
About Lizada Capital LLC:
Lizada is a privately held entity formed in 2004 for the principal purpose of investing in emerging market opportunities. In 2013, following a two-year period of industry evaluation, the company started primarily focusing on the cannabis industry, Since then, Lizada has invested in public companies including GW Pharmaceuticals, AmeriCann and CannLabs and private companies, CDX, MJIC, Panther Capital, New Frontier, Noble Blends, Medicine Man Technologies, Las Vegas CannaPlex and Quigley's.
GREAT NEWS LAST NIGHT. GOOD FOR THE COMPANY.
Medbox Founder Comments on Signing $15M Equity Deal
Founder Further Comments on Signing a Deal Transferring the Majority of His Shares to an Industry Player and Directing $5M of the Proceeds to Medbox Through Equity Purchase
P. Vincent Mehdizadeh
15 hours ago
GlobeNewswire
LOS ANGELES, March 5, 2015 (GLOBE NEWSWIRE) -- P. Vincent Mehdizadeh, founder and current majority shareholder of Medbox, Inc. (MDBX) commented on executing a deal with Lizada Capital LLC, an investor in the field of legal cannabis products, that would result in the transfer of the majority of Mr. Mehdizadeh's shares of MDBX to that firm.
Under the agreement, which has six separate closings over 18 months, Lizada would purchase 22,160,000 shares, representing 2,000,000 preferred shares and 12,160,000 common shares of Medbox for upwards of $15 million. A total of $5 million of the funds have been designated for purchase of 2.5 million restricted shares of Medbox common stock, directly from Medbox, in the name of Mr. Mehdizadeh's holding company, PVM International, Inc.
"Prior to announcing the deal yesterday, the Medbox board of directors had approved the Lizada Capital LLC managing member to join the board of directors as my board appointment and also approved of that party making a substantial direct investment into the company for the purchase of restricted common stock," stated Vincent Mehdizadeh, founder and current majority shareholder of Medbox. "I also discussed the possibility of having Lizada step into my shoes as the majority shareholder of the company and shared the potential deal points with the Medbox board of directors and their attorneys weeks before a final agreement was reached with Lizada. While Medbox is not a direct party to this transaction, they have been in the loop and have been supportive in vetting Lizada's investment and its managing member's appointment to the Medbox board of directors. The next steps for the investment into Medbox will be signing subscription agreements with the company that will tie into each of the first 5 closings identified within the Lizada transaction. From what my attorneys and I can gather, the signing of subscription agreements with Medbox is simply a formality. I am happy to be bringing value to Medbox and its shareholders in this manner."
To view a copy of the executed agreement between the parties, please click on the link below:
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=10537768
About P. Vincent Mehdizadeh, Founder and Majority Shareholder at Medbox, Inc.
P. Vincent Mehdizadeh founded Medbox's main subsidiary, Medicine Dispensing Systems, in February 2008. He commenced operations for that company in 2010, and in December of 2011 sold that company to what became Medbox, Inc. Mr. Mehdizadeh served as senior consultant from December 2012 until May 10, 2013 for Medbox, Inc. and then transitioned to Chief Operations Officer and Board Chairman for Medbox, Inc. through May of 2014. Mr. Mehdizadeh was responsible for creating the two main patents behind the company's technology, helping to assemble the talented board/management team at Medbox, and also developing the concept behind the business models driving revenue for the company. Mr. Mehdizadeh was responsible for funding and the creation of the Marijuana Policy Project "Consume Responsibly" campaign, as well as the Americans For Safe Access "Medicate Responsibly" campaign. Mehdizadeh has donated over $2 million dollars to Americans for Safe Access (ASA), Marijuana Policy Project (MPP), Drug Policy Alliance (DPA), Law Enforcement Against Prohibition (LEAP), and St. Jude Children's Research Hospital.
About Lizada Capital LLC:
Lizada is a privately held entity formed in 2004 for the principal purpose of investing in emerging market opportunities. In 2013, following a two-year period of industry evaluation, the company started primarily focusing on the cannabis industry, Since then, Lizada has invested in public companies including GW Pharmaceuticals, AmeriCann and CannLabs and private companies, CDX, MJIC, Panther Capital, New Frontier, Noble Blends, Medicine Man Technologies, Las Vegas CannaPlex and Quigley's.
I don't think so. Expecting a good day today. Too strong of a close yesterday. This stock is ready to pop any time now.
I would like to buy more but only doing it if we dip below .015. Otherwise not adding at this point. We have already come close but it jumped back up. Have a feeling it will happen.
Nice close today all things considered. Strong at the end. Easy $3-$5 stock with some positive news. Way under valued at this price. I am liking it!
Lol wrong. They will make much more than that on the shares if it goes above and beyond 5. Nice math.
MDBX. Per latest news release, former founder of company just signed an investment deal where he gets an added 5 million dollars if the stock trades above $5 per share. Currently at $2. Great incentive to push the stock price up! I am betting it happens.
Exactly my thought!!
What a let down today. Thought for sure we would have huge gap up.
MDBX.....Get your running shoes on, we have a runner!